LMR Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.68M | Buy |
19,373
+16,490
| +572% | +$1.58M | ﹤0.01% | 882 |
|
|
2025
Q4 | $277K | Sell |
2,883
-4,763
| -62% | -$463K | ﹤0.01% | 1227 |
|
|
2025
Q3 | $728K | Buy |
7,646
+7,643
| +254,767% | +$703K | ﹤0.01% | 1022 |
|
|
2025
Q2 | $262 | Sell |
3
-33,806
| -100% | -$2.87M | ﹤0.01% | 1345 |
|
|
2025
Q1 | $3.04M | Buy |
33,809
+29,044
| +610% | +$2.6M | 0.03% | 554 |
|
|
2024
Q4 | $381K | Sell |
4,765
-96,106
| -95% | -$8.32M | ﹤0.01% | 871 |
|
|
2024
Q3 | $9.08M | Buy |
+100,871
| New | +$8.49M | 0.07% | 231 |
|
|
2024
Q1 | – | Sell |
-43,058
| Closed | -$3.67M | – | 1252 |
|
|
2023
Q4 | $3.55M | Buy |
43,058
+14,287
| +50% | +$1.09M | 0.04% | 391 |
|
|
2023
Q3 | $2.25M | Buy |
+28,771
| New | +$2.41M | 0.03% | 381 |
|
|
2022
Q2 | – | Sell |
-4,267
| Closed | -$473K | – | 1388 |
|
|
2022
Q1 | $473K | Buy |
+4,267
| New | +$451K | 0.01% | 1008 |
|
|
2021
Q2 | – | Sell |
-11,424
| Closed | -$1.35M | – | 1245 |
|
|
2021
Q1 | $1.35M | Buy |
+11,424
| New | +$1.34M | 0.03% | 418 |
|
|
2020
Q1 | – | Sell |
-17,188
| Closed | -$1.95K | – | 370 |
|
|
2019
Q4 | $1.95K | Buy |
17,188
+9,853
| +134% | +$1.08M | ﹤0.01% | 133 |
|
|
2019
Q3 | $797K | Buy |
+7,335
| New | +$765K | 0.04% | 206 |
|
|
2019
Q2 | – | Sell |
-72,700
| Closed | -$6.62M | – | 524 |
|
|
2019
Q1 | $6.62M | Buy |
72,700
+65,620
| +927% | +$5.87M | 0.34% | 51 |
|
|
2018
Q4 | $644K | Buy |
+7,080
| New | +$662K | 0.03% | 238 |
|
|
2017
Q3 | – | Sell |
-6,099
| Closed | -$541K | – | 462 |
|
|
2017
Q2 | $541K | Buy |
6,099
+3,089
| +103% | +$260K | 0.03% | 403 |
|
|
2017
Q1 | $242K | Sell |
3,010
-29,950
| -91% | -$2.34M | 0.02% | 321 |
|
|
2016
Q4 | $2.35M | Buy |
32,960
+22,190
| +206% | +$1.74M | 0.36% | 52 |
|
|
2016
Q3 | $931K | Buy |
10,770
+4,647
| +76% | +$405K | 0.09% | 202 |
|
|
2016
Q2 | $531K | Sell |
6,123
-10,034
| -62% | -$811K | 0.08% | 277 |
|
|
2016
Q1 | $1.21K | Buy |
16,157
+13,528
| +515% | +$1.02M | 0.13% | 152 |
|
|
2015
Q4 | $203K | Buy |
+2,629
| New | +$198K | 0.07% | 206 |
|
|
2015
Q2 | – | Sell |
-16,810
| Closed | -$1.31M | – | 582 |
|
|
2015
Q1 | $1.31M | Buy |
+16,810
| New | +$1.27M | 0.18% | 154 |
|
Other funds holding MDT
VCM
VPM
LMR Partners's MDT Position: Q1 2026 in Review
LMR Partners increased its Medtronic (MDT) stake by 572% in Q1 2026, buying an estimated $1.58M and bringing the position to 19,373 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #882.
LMR Partners first reported a position in MDT in Q1 2015 and has held it in 23 quarters since. The position peaked at $9.08M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- LMR Partners held 19,373 shares of Medtronic worth $1.68M as of Q1 2026.
- LMR Partners bought 16,490 Medtronic shares in Q1 2026, an estimated $1.58M.
- Medtronic made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #882 holding.
- LMR Partners first reported a position in Medtronic in Q1 2015 and has held it in 23 quarters since.
- LMR Partners's Medtronic position peaked at $9.08M in Q3 2024.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.